TuHURA Biosciences Inc. (HURA)
NASDAQ: HURA
· Real-Time Price · USD
3.06
0.30 (10.87%)
At close: Aug 15, 2025, 3:59 PM
3.00
-2.12%
After-hours: Aug 15, 2025, 07:58 PM EDT
TuHURA Biosciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 17.64K | 15K | 15K | 30K | 30K | 30K | 45K | 45K | 60K | 60K | 60K | 60K | 60K | 46K | 32K | 18.55K |
Gross Profit | -17.64K | -15K | -15K | -30K | -30K | -30K | -45K | -45K | -60K | -60K | -60K | -60K | -60K | -46K | -32K | -18.55K |
Operating Income | -12.51M | -7.83M | -5.63M | -8.98M | -23.12M | -25.6M | -30.24M | -32.35M | -18.96M | -21.36M | -22.68M | -23.92M | -25.17M | -24.65M | -21.57M | -17.64M |
Interest Income | 170.82K | 8.64K | 8.64K | 22.64K | 49.55K | 92.55K | 131.55K | 128.55K | 96K | 52K | 14K | 4K | 4K | 4K | 4K | 4.28K |
Pretax Income | -13M | -8.03M | -5.87M | -9.2M | -23.07M | -25.5M | -30.09M | -32.2M | -18.85M | -21.29M | -22.66M | -23.95M | -25.23M | -24.75M | -38.3M | -35.39M |
Net Income | -10.84M | -5.87M | -5.87M | -9.2M | -23.07M | -25.5M | -30.09M | -32.2M | -18.85M | -21.29M | -22.66M | -23.95M | -25.23M | -24.75M | -38.3M | -35.39M |
Selling & General & Admin | 4.67M | 3.87M | 1.91M | 3.17M | 3.08M | 3.61M | 5.07M | 5.25M | 6.19M | 6.75M | 7.45M | 8.66M | 9.54M | 10.35M | 9.72M | 8.54M |
Research & Development | 7.82M | 3.95M | 3.7M | 5.78M | 3.81M | 5.76M | 8.92M | 10.85M | 12.71M | 14.55M | 15.17M | 15.2M | 15.57M | 14.25M | 11.81M | 9.08M |
Other Expenses | n/a | n/a | n/a | n/a | 16.2M | 16.2M | 16.2M | 16.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.49M | 7.82M | 5.61M | 8.95M | 23.09M | 25.57M | 30.19M | 32.3M | 18.9M | 21.3M | 22.62M | 23.86M | 25.11M | 24.61M | 21.54M | 17.62M |
Interest Expense | 777.96K | 255.12K | 255.12K | 255.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 27K | 57K | 90K | 125K | 98K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.12M | 5.8M | 3.59M | 242.32K | 14.38M | 11.9M | 7.25M | 5.14M | -18.96M | -21.36M | -22.68M | -23.92M | -25.17M | -24.65M | -21.57M | -17.64M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 423.24K | 420.3K | 118.89K | 420.3K | 123.91K | 86.13K | 48.34K | 47.31K | 46.94K | 41.83K | 37.45K | 28.07K | 27.73K | 19.59K | 18.71K | 16.73K |
Shares Outstanding (Diluted) | 423.24K | 420.3K | 118.89K | 420.3K | 123.91K | 86.13K | 48.34K | 47.31K | 46.94K | 41.83K | 37.45K | 28.07K | 27.73K | 19.59K | 18.71K | 16.73K |
EPS (Basic) | -25.83 | -19.93 | -19.97 | -88.87 | -472.77 | -538.12 | -656.64 | -733.1 | -528.54 | -667.51 | -979.28 | -1.19K | -1.4K | -1.57K | -3.46K | -3.69K |
EPS (Diluted) | -25.83 | -19.93 | -19.97 | -88.87 | -472.77 | -538.12 | -656.64 | -733.1 | -528.54 | -667.51 | -979.28 | -1.19K | -1.4K | -1.57K | -3.46K | -3.69K |
EBITDA | -12.2M | -7.75M | -5.57M | -8.89M | -22.98M | -25.41M | -29.99M | -32.1M | -18.79M | -21.23M | -22.6M | -23.86M | -25.11M | -24.61M | -38.14M | -35.27M |
EBIT | -12.27M | -7.82M | -5.61M | -8.95M | -23.07M | -25.5M | -30.09M | -32.2M | -18.85M | -21.29M | -22.66M | -23.92M | -25.17M | -24.66M | -38.17M | -35.29M |
Depreciation & Amortization | 80.94K | 78.31K | 64.31K | 79.31K | 60K | 60K | 60K | 60K | 60K | 60K | 60K | 60K | 60K | 46K | 32K | 18.55K |